“Many vs. Cancer represents the final push to defeat prostate cancer once and for all. PCF has raised more than $700 million for prostate cancer research to date, which has resulted in great strides and decreased the death rate in prostate cancer by 53 percent so far, Dr. Simons, MD, President and CEO. He is optimistic. “We are on the cusp of defeating this deadly disease. We know what has to be done to get us to the finish line, and now it’s simply a matter of money.”
All the more promising is the news that the “The defeat of prostate cancer will result in cures for 16 other cancers that have genetic similarities.”
In mid-May, 2017, the Many vs. Cancer Initiative awarded support for a research project led by Matthew Rettig, MD, Professor of Medicine and Oncology and Medical Director of the Prostate Cancer Program at the David Geffen School of Medicine at UCLA. Dr. Rettig accepted this honor, with remarks on the hope and promise of his research effort: “The work we are doing at UCLA will help researchers create more informed, precision treatment strategies that will improve the quality and extend the lives of those suffering from prostate Cancer.”
About the Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $700 million and provided funding to more than 2,000 research programs at more than 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of government research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.
Written by: Courtney Leonard, a medical writer for UroToday